Vaishali Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2025
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaishali Pharma Limited has submitted the Scrutinizer's Report from its 18th Annual General Meeting held on September 22, 2025, via video conferencing. Three resolutions were put to vote: (1) adoption of audited financial statements for FY ended March 31, 2025, passed with 99.998% votes in favour; (2) re-appointment of Mr. Dewansh Vasani as Director (retiring by rotation), passed with 99.9946% votes in favour, with promoter group abstaining; and (3) appointment of HD & Associates as Secretarial Auditor, passed with 99.9097% votes in favour. A total of 28,389 shareholders were on record as of September 15, 2025, with 7 from promoter group and 44 from public attending the meeting through video conferencing. All three resolutions were passed with overwhelming majority.
This is a routine regulatory filing confirming that key annual resolutions — financial approval, director re-appointment, and secretarial auditor appointment — were approved by shareholders. No negative signals; all resolutions passed with near-unanimous support, indicating stable shareholder confidence.